Dr. David Coughlin, MD

Dr. Coughlin practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Coughlin's NPI, 1740543784, was assigned on June 22, 2012. Dr. Coughlin graduated from Vagelos College of Physicians and Surgeons in 2012. Dr. Coughlin holds California license A162063.

Dr. Coughlin's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Coughlin's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Coughlin is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coughlin practices. Vendor and product names are available with a free account.

Neurology is Dr. Coughlin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Coughlin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Coughlin's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists essential tremor, lower back pain, muscle pain, fibromyalgia, and limb pain, non-alzheimer's dementia (chronic), parkinson's disease and restless legs syndrome among the conditions Dr. Coughlin treats.

CMS data shows 11,054 Medicare services from Dr. Coughlin across 7 procedure codes in 2024, for 177 Medicare patients. Medicare paid $89,635 for them.

CMS counts 177 Medicare patients who saw Dr. Coughlin in 2024. The largest group is 75 to 84, with 78 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coughlin's median patient age at 70, with 42% women.

In 2024, Dr. Coughlin wrote 702 Medicare Part D claims for 122 patients. 81% of them were for generic drugs. CMS names the drug for 538 of them, across 15 drugs with 11 or more claims each, at $398,852 in total drug cost. In 2023, CMS named 681 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Coughlin for performance year 2024, reported as part of a group. Dr. Coughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Coughlin as offering telehealth.

Dmand AI links 51 papers to Dr. Coughlin, published from 2012 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Alzheimer Disease, Brain and Lewy Body Disease. Dr. Coughlin has published most often in Mov Disord. Dr. Coughlin's most frequent co-authors are David J. Irwin, MD, Irene Litvan, MD and Douglas R. Galasko, MD.

Dmand AI links Dr. Coughlin to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Anosmia.

CMS Open Payments shows 49 general payments to Dr. Coughlin from 15 drug and device companies from 2016 to 2025. Grants make up the largest share, 95% of the total. Medtronic USA, Inc. paid the most, $43,837.

Dmand AI lists 8 awards for Dr. Coughlin, most recently Whitehill Award For Research and Mentoring in 2021.

Dr. Coughlin graduated from Vagelos College of Physicians and Surgeons in 2012. Dr. Coughlin is a member of AOA, AAN, American Neurological Association, Movement Disorder Society, Parkinson’s Study Group and San Diego Neurosciences Society.

Dr. Coughlin is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.